Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Jul 30, 2015, after the close
10-Q filed Jul 30, 2015, 30 days after period end · 0001396814-15-000009
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Revenue | $59.15M | $47.17M | $17.14M | $12.34M |
| Net Income | $8.00K | -$5.04M | -$14.03M | -$8.30M |
| EPS Diluted | $0.00 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.14 |
| -$0.42 |
| -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.